Jump to content
Powered by

2022 Research Grants – Drug Discovery

Type
Funding programme
Submission deadline
Funded by
Merck KGaA

The following text does not reflect the entire content of the announcement, but contains individual extracts from the guideline.

In 2022, we are offering a series of research grants to stimulate innovative research in challenging areas of future importance. Grants of up to 500,000 € per year for up to 3 years are available in the areas as further specified below.

  • Drug discovery - 3 grants comprising up to 500,000 €/year for 3 years with the option of extension.
  • AI for predictive diagnostics & therapeutic target discovery - grant comprising between 100,000 - 300,000 $/year for 2 years with the option of extension
  • Chemistry in the cloud – Rapid synthesis through automation - 1 grant comprising 100,000 €/year for 3 years
  • Innovation within green chemistry - 1 grant comprising 100,000 € for 1 year with potential further collaboration
  • Sustainability in healthcare R&D - 1 grant comprising 100,000 € for 1 year

About the 2022 Reserach Grants

The Merck research grants program is open to scientists in all career stages who are affiliated with any research-based institution, university or company.

In the first stage of the Research Grants applications process, applicants submit their application containing non-confidential information only. You may apply for more than one grant or submit your application for more than one category. If your application is successful, you are invited to submit a full proposal under confidentiality and join a deep-dive workshop. All applicants are informed about the decision of the selection committee.

Submission deadline is 31 August 2022.

Deep Dive Workshops

The second stage of the Research Grant process is a collaborative step, the deep-dive workshop. Finalists submit their full proposals and then work together with Merck managers and scientists to jointly optimize submitted project proposals. All teams reaching this stage will be informed in October. The deep-dive workshops will take place in November 2022. The culmination of the deep-dive workshops will be the selection of the research grant winners.

Reserach Grant Funding

The third stage of the Research Grants process is the Research Grant funding phase. To enable pay-out and project start, Merck enters into bilateral collaboration agreements with the winning recipients. Our collaborative Research Grants are a unique opportunity for researchers who are interested in working with Merck‘s scientists and receive guidance from industry. During the Research Grant funging period, there will therefore be regular meetings with Merck scientists.

Call for Reserach Proposal

Drug Discovery

We are launching a call for research proposals advancing the field of drug discovery and are looking for proposals for projects to identify and characterize the next game-changing molecule to help cure cancer, autoimmune/neuroinflammatory disease or infertility. In addition, approaches interfering with the molecular hallmarks of aging to promote healthy longevity are of interest.

Your proposal should address one of the following:

  • Cancer/Autoimmune Targets/Infertility: Which molecular targets or pathophysiological pathways have tremendous untapped potential to deliver the next big therapeutic breakthrough?
  • Enabling Technologies: What are new enabling technologies for drug discovery? How can molecular strategies for tissue-targeting and tissue-sparing look like?
  • Translation: How can translation from and predictivity of preclinical models to the clinical situation be enhanced and how can quantitative methods enable this?
  • Senescence and Anti-Aging: How can our evolving understanding of senescence and age-related changes be translated into new drug discovery approaches for cancer, autoimmunity, neuroinflammation, infertility, pandemic preparedness and anti-aging?
Website address: https://www.gesundheitsindustrie-bw.de/en/database/funding/2022-research-grants-drug-discovery